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Abstract Cellulose-binding domains (CBDs) form distinct func- 
tional units of most cellulolytic enzymes. We have compared the 
cellulose-binding affinities of the CBDs of ceilobiohydrolase 1 
(CBHI) and endoglucanase I (EGI) from the fungus Trichoderma 
reeseL The CBD of EGI had significantly higher affinity than that 
of CBHI. Four variants of the CBHI CBD were made in order 
to identify the residues responsible for the increased affinity in 
EGI. Most of the difference could be ascribed to a replacement 
of a tyrosine by a tryptophan on the flat cellulose-binding face. 
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1. Introduction 
Most cellulolytic enzymes have a domain organization, con- 
sisting of a catalytic domain and a cellulose-binding domain 
(CBD). The CBDs of fungal enzymes are very similar in their 
amino acid sequence and size [1]. These small domains are 
responsible for most of the enzyme's affinity for cellulose [2-5]. 
The cellulose binding mediated by the CBD is essential for the 
enzymatic activity on crystalline cellulose, but has no effect on 
the hydrolysis of soluble substrates. The most thoroughly stud- 
ied fungal CBD is that of cellobiohydrolase I (CBHI) from the 
filamentous fungus Trichoderma reesei. This is the major cellu- 
lolytic enzyme of the fungus, and it is capable of efficient hy- 
drolysis of crystalline cellulose. The three-dimensional struc- 
ture of the CBHI CBD has been solved [6], permitting detailed 
structure-function studies [3,4,7]. So far three tyrosines, one 
glutamine and one asparagine have been proposed to partici- 
pate in the binding. Together they form a distinct fiat binding 
face of the folded peptide. The presence of tyrosyl or other 
aromatic residues in the binding face is typical for carbohy- 
drate-protein teractions [8]. 
In the hydrolysis of cellulose CBHI acts synergistically with 
a homologous endoglucanase, EGI. Despite the close similarity 
between their CBDs, some results suggest hat the EGI CBD 
has a higher affinity towards cellulose [9]. Here we have carried 
out a detailed comparison of the two CBDs, and by means of 
specific amino acid substitutions investigated the molecular 
basis of the difference between the CBDs. 
*Corresponding author. Fax: (358) (0) 455-2103. 
Abbreviations." CBD, cellulose-binding domain; CBHI, cellobiohydro- 
lase I; EGI, endoglucanase I. 
2. Materials and methods 
2.1. Peptides 
Peptides were synthesized using Fmoc chemistry and purified as 
described in [10]. The purified peptides were characterized by time-of- 
flight plasma desorption mass-spectroscopy and amino acid analysis. 
2.2. Adsorption of peptides to cellulose 
Lyophilized peptide was dissolved in 50 mM sodium acetate buffer, 
pH 5.0, containing 50 mM NaC1. The peptide concentration was deter- 
mined by amino acid analysis and UV absorbance at 280 nm. Dilutions 
of the peptide were made with the same buffer. A suspension (2 mg/ml) 
of tunicate cellulose (kindly provided by Daicel Co., Japan) in Milli-Q 
water and an equal volume of peptide in was mixed for 20-25 h at 4°C 
with a magnetic stirrer. The suspension was then centrifuged (4000 rpm, 
10 min) and the concentration ofpeptide in the supernatant was deter- 
mined by analytical reversed phase high performance liquid chromatog- 
raphy (HPLC). A water/acetonitrile gradient with 0.1% trifluoroacetic 
acid was used for elution. 
3. Results and discussion 
The binding isotherms for the wild-type CBHI and EGI CBD 
peptides clearly show that the affinity of the EGI CBD is mark- 
edly higher than that of the CBHI CBD (Fig. 1). As seen in Fig. 
2 the amino acid sequences of the two CBDs are very similar, 
only 9 out of the 36 amino acids are different. The amino acid 
differences are indicated on the structure of the CBHI CBD, 
revealing their occurrence in three or four clusters (Fig. 3). Only 
one of the substitutions, tyrosine-5 of CBHI to a tryptophan 
in EGI, clearly changes a part of the binding face (Fig. 3). The 
changes P30(D), L28(S), V27(Y) occur near the tip of the 
wedge-shaped CBD. In the structure of CBHI CBD, the side 
chain of L28 points towards the fiat face, and that of V27 
towards the rough face and P30 forms the tip. The cluster with 
changes T17(K), V18(T) and A20(T) is found on the rough face, 
with the side chain of A20 in CBHI pointing away from it. 
Apparently, the cysteine in the EGI CBD at position 16 forms 
a disulfide bridge with another cysteine near the N-terminus. 
As the sequences of the two CBDs are so similar, their three- 
dimensional structures are presumably also conserved [I 1]. As- 
suming that the positions of the residues in EGI CBD are the 
same as those in the CBHI CBD, we designed a set of four 
variants of the CBHI CBD. The hybrids constructed were 
T 17K: V 18T: A20T, P30D, V27Y: L28S: P30D and Y5W. Their 
binding to crystalline cellulose was determined in order to iden- 
tify residues responsible for the increased affinity of the EGI 
CBD. It should be noted that the CBDs used here were made 
synthetically, and that we have demonstrated arlier, in the case 
of CBHI that there is no difference in binding between the 
natural and synthetic CBDs [12]. 
The effects of the amino acid substitutions are shown in the 
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Fig. 1. Adsorption isotherms of the wild-type CBHI and EGI CBD. 
binding isotherms in Fig. 4. All of the variants except Y5W had 
a lower affinity than the wild-type CBHI CBD. The substitu- 
tion in Y5W significantly increased the affinity, although not 
to the level of wild-type EGI CBD. Partition coefficients [13] 
were calculated for EGI, Y5W and CBHI from the initial slopes 
of the curves. The values are 5.2, 2.8 and 1.7 litres/g, respec- 
tively. Assuming that all CBDs have the same number of bind- 
ing sites on cellulose, the difference in free energy of binding 
between the mutants and wild-types was calculated from the 
formula: 
AAG = - RT"  In(K, /  Kb) (1) 
where /Ca and Kb are the respective distribution coefficients, 
R is the gas constant and T is the temperature. The eollow- 
ing values were obtained: AAGcBm_~vsw=-I.1 kJ/mol, 
AAGvsw_~ECL = -1.4 kJ/mol and ztAG('I3HI~EGI = --2.4 kJ/mol. 
The physical basis of the difference in affinity is not obvious. 
The interaction between pyranose and aromatic rings in carbo- 
hydrate-binding proteins is well established [8,14[, but the na- 
ture of this phenomenon is not yet clear. Hydrophobicity has 
been suggested to play a key role in aromatic ring-sugar inter- 
actions and in the CBD-cellulose interaction [4,15]. In this case 
the difference in hydrophobicity might offer an explc, nation, 
since the indole side chain of tryptophan is more hydropbobic 
than the phenol group of tyrosine. The difference in free energy 
change upon transferring these side chains from water to cyclo- 
hexane has been measured to be 10.32 kJ/mol, which gives an 
estimate of the magnitude of their difference in hydrophobicity 
[16]. Other plausible xplanations can be, for example, the dif- 
ference in charge-transfer p operties between the phenol and 
the indole aromatic systems. Since heteroatoms polarize ~r- 
systems and because the 1r-systems of tyrosine and tryptophan 
are of different sizes, one can argue that the charge distribu- 
tions and van der Waals interactions should be different, which 
results in the different affinities [17]. It is not possible to quan- 
tify these effects in terms of the cellulose affinity, but they still 
offer plausible xplanations. The affinity of the CBD does not, 
of course, depend solely on the enthalpic forces between the 
protein and carbohydrate, but also on the difference in free 
energy of solvation of the parts and the complex. 
The other mutations introduced to the CBHI CBD decreased 
its affinity, and even the mutation Y5W, which increased the 
affinity, did not restore the wild type EGI CBD affinity. There- 
fore, there must be some other factors involved which were not 
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Fig. 2. Sequence alignment of the CBHI and EGI CBDs [21,22]. Amino 
acids strictly conserved in homologous equences are shown in bold. 
In positions 5, 13 and 31 the residues are not strictly conserved, but the 
aromatic haracter of the residues is. Those amino acids which were 
investigated in this study are marked with boxes. The numbering used 
is based on the CBHI-CBD for clarity when comparing with other work 
[3,6,7]. 
possible to probe in this way, or which were not investigated. 
This difference might well be attributed to the putative third 
disulfide of EGI CBD. The disulfide could lock the interacting 
residues in a favorable position, whereas a CBD without the 
disulfide would have to pay a entropic penalty when positioning 
the side chains for binding. Other amino acid differences might 
also be involved in the optimization of conformation. We have 
shown previously that the conformation of the loop accommo- 
dating Y5 is sensitive towards conformational changes caused 
by mutations [7]. 
Although the other substitutions did not considerably 
change the affinity, they are still very informative. In 
T17K:V18T:A20T one hydrophilic residue was changed to a 
charged residue and two hydrophobic residues were changed 
to hydrophilic residues. The amphiphilicity of the wild-type [6] 
was thus clearly disrupted. It seems that as long as no structure- 
breaking changes are made, these residues can be varied with- 
out much effect on the binding. The substitution in P30D is 
special because in 12 out of 13 homologous CBD sequences, 
this position was occupied by either proline or aspartic acid [7]. 
This side chain is close to the binding face, but not well posi- 
tioned for interaction with cellulose. The mutation P30D 
caused the largest decrease in the affinity, most likely due to a 
perturbation of the side chain of Y31, which does bind to 
cellulose [7]. In V27Y:L28S:P30D an additional aromatic res- 
idue was placed on the surface of the peptide. All these three 
residues were changed simultaneously since they seem to be 
connected in other homologous equences. Interestingly, Y27 
, ,.,~ ~ j T ~ . -  L28(S)  r ~ i 
Fig. 3. c~-Carbon trace of the CBHI CBD with some important side 
chains hown in darker shade. The three tyrosines form the flat cellulose 
binding face of the peptide. The other side chains indicated are different 
in the EGI CBD, with the corresponding EGI residue shown in pa- 
renthesis. The figure also shows the wedge-shaped fold of the peptide. 
The binding face is referred to as the 'flat face' and the opposite face 
is referred to as the 'rough face'. (Figure adapted from entry 1CBH in 
the Brookhaven Data Bank [23].) 
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Fig. 4. Low concentration region of the adsorption isotherms of the 
variant and wild-type CBDs. 
and $28 together compensate part of the decrease observed 
when P30 was changed alone. 
Fig. 1 shows that a saturating level of CBD on cellulose was 
not quite achieved. However, both wild-type isotherms eem to 
converge to some value in excess of 25/tmol/g cellulose. Using 
the approximate dimensions of 3 x 2 nm for the CBHI CBD [6] 
and assuming a monolayer, a minimum covered area of 90 m2/g 
cellulose can be calculated. Accessible crystalline surface areas 
are not easily measured for cellulose, but some calculations can 
be made on the basis of the microfibril dimensions obtained 
from electron micrographs. The diameter of tunicin microfi- 
brils has been estimated at 10 nm [18] and the density of Ip 
cellulose has been calculated to be 1.6 g/cm 3 [19]. From these 
values a theoretical maximum crystalline surface area of 250 
m2/g can be calculated. These calculations thus indicate that 
somewhat less than half of the surface would be covered by 
CBDs, provided that the binding itself does not change the 
surface. It should be noted that the surface of crystalline cellu- 
lose is equally divided between two distinctly different ypes, 
potentially providing two types of binding sites [20]. 
The results are in good agreement and support earlier con- 
clusions that the flat face binds to cellulose and that the rough 
face is not involved in binding. It is noteworthy that the CBHI 
enzyme could, by a single amino acid substitution acquire a 
higher affinity towards cellulose. If a higher affinity offered 
CBHI a selective volutionary advantage, i.e. better productiv- 
ity, such a mutation could easily have occurred during evolu- 
tion. Since this has not happened it is tempting to assume that 
the affinity of CBHI is balanced for optimum performance of 
the enzyme. Indeed, our preliminary data obtained with a hy- 
brid CBHI with the EGI CBD instead of its own, revealed 
improved binding but no changes in the enzymatic activity of 
CBHI [9]. On the other hand, mutations decreasing the affinity 
of the CBHI CBD do decrease its catalytic activity on crystal- 
line cellulose [3,4]. Therefore, it is possible that beyond a cer- 
tain, relatively high affinity of the CBD slight increases will no 
longer improve the enzymatic activity on crystalline cellulose. 
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